Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Hugues Legendre"'
Autor:
Sébastien Debroux, Hugues Legendre, Ahmad Awada, Alain Hendlisz, Nicolas Sirtaine, Julien Gatlez
Publikováno v:
Acta Clinica Belgica. 62:433-437
The squamous cell carcinoma and the adenosquamous cell carcinoma of the colon and rectum are not well know and rare tumours. We report a case of squamous cell carcinoma of the recto-sigmoid who relapses in the liver after surgery of the primary tumou
Autor:
Hugues Legendre, Thierry Delaunoit, Alain Hendlisz, Pierre Eisendrath, Raphaël Maréchal, Harry Bleiberg, Jean Claude Pector, Daniel De Becker
Publikováno v:
Anti-Cancer Drugs. 15:725-728
The combination of 5-fluorouracil (5-FU) modulated by folinic acid (FA) and cisplatin is commonly used in advanced digestive non-colon cancers (ADNCC). In order to simplify treatment administration by avoiding cisplatin-related hydration, we investig
Publikováno v:
Annales de Chirurgie. 129:278-281
Resume Introduction. – Le melanome est caracterise par sa tendance a metastaser. Sur le tractus digestif, les sites les plus frequemment envahis sont par ordre decroissant l'intestin grele, l'estomac et le colon. Le traitement chirurgical des metas
Autor:
Isabelle Salmon, Alain Hendlisz, Christine Decaestecker, Robert Kiss, Jean Claude Pector, Nathalie Nagy, Hans-Joachim Gabius, Max-Peter Schüring, Hugues Legendre
Publikováno v:
Modern Pathology. 16:491-504
This study aims to investigate whether the immunohistochemical levels of expression of galectin-3 and the macrophage migration inhibitory factor (MIF) are associated with prognostic values in human colorectal tumors. This was performed on 99 specimen
Autor:
Herbert Kaltner, Kojiro Wasano, Yehiel Zick, Olivier Engels, Hugues Legendre, Isabelle Salmon, Christine Decaestecker, Sabine André, Nathalie Nagy, Hans-Joachim Gabius, Robert Kiss, Jean Claude Pector
Publikováno v:
Cancer. 97:1849-1858
BACKGROUND: Knowledge of the expression of the galectins in human colon carcinomas is mainly restricted to galectin-3 and, to a lesser extent, galectin-1. The current study analyzed the prognostic values contributed by galectin-1, galectin-3, galecti
Autor:
Hugues Legendre, Hans-Joachim Gabius, Yaron R. Hadari, Paul Yeaton, Nathalie Nagy, Harald Lahm, Yehiel Zick, Isabelle Salmon, André Danguy, Robert Kiss, Jean Claude Pector, Yves Bronckart, Isabelle Camby, P. Van Ham, Herbert Kaltner
Publikováno v:
Gut. 50:392-401
Background and aims: Galectins are β-galactoside binding proteins. This ability may have a bearing on cell adhesion and migration/proliferation in human colon cancer cells. In addition to galectins-1 and -3 studied to date, other members of this fam
Publikováno v:
European Journal of Surgical Oncology (EJSO). 27:364-367
Objective The aim was to identify the prognostic factors which relate to the results, in terms of survival and quality of life, of palliative surgery in cancer patients presenting with an occlusion. Methods The files of 109 patients with a neoplasm w
Autor:
Claude Bertrand, Eric Van Cutsem, Joseph Kerger, Marc Peeters, Kurt Van der Speeten, André D'Hoore, Steffen Fieuws, Wim Ceelen, Daphne Hompes, Hugues Legendre
Publikováno v:
Annals of surgical oncology. 19(7)
Up to 25% of patients with metastatic colorectal cancer (CRC) present with peritoneal carcinomatosis (PC) as the only site of metastases. Complete cytoreductive surgery (CCRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) aims for loc
Autor:
Benjamin Henriet, S. De Cooman, Hugues Legendre, Gabriel Liberale, Jean Alexiou, Jean Claude Pector, Anis Akalay
Publikováno v:
Europe PubMed Central
Autor:
Fréderic Berthier, Harry Bleiberg, Alain Hendlisz, Nathalie Baize, Hugues Legendre, Béatrice Gerard, Jean Claude Pector, François Caroli-Bosc
Publikováno v:
Gastroenterologie clinique et biologique. 30(12)
Summary Objectives To evaluate long-term survival of patients resected for primarily unresectable colorectal liver metastases downstaged by systemic chemotherapy. Methods Among a group of 82 patients with advanced colorectal cancer, 39 had unresectab